Results 191 to 200 of about 2,202,984 (265)
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source
A Strategy Against Antibiotic-Resistant Bacteria: Optimizing Prevention of Transmission. [PDF]
Kemp M +5 more
europepmc +1 more source
Control of human African trypanosomiasis in the Quiçama focus, Angola
Ruiz José Antonio +2 more
doaj
Finite-time robust motion control of intelligent vehicles based on neural approximation and disturbance estimation. [PDF]
Zhang L.
europepmc +1 more source
Research Priorities of Children and Young People with Type 1 Diabetes: A Qualitative Study of Age-Specific Needs. [PDF]
Sharpe DM +3 more
europepmc +1 more source
Economic Scarcity Impedes Impoverished Children's Executive Function: The Role of Multiple Resources Examined Through Eye Tracking. [PDF]
Jiang Y, Zhang F, Ming H, Li H, Huang S.
europepmc +1 more source

